These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


758 related items for PubMed ID: 14517168

  • 21. Critical role for leukocyte hypoxia inducible factor-1alpha expression in post-myocardial infarction left ventricular remodeling.
    Dong F, Khalil M, Kiedrowski M, O'Connor C, Petrovic E, Zhou X, Penn MS.
    Circ Res; 2010 Feb 19; 106(3):601-10. PubMed ID: 20035082
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction.
    Ikeuchi M, Tsutsui H, Shiomi T, Matsusaka H, Matsushima S, Wen J, Kubota T, Takeshita A.
    Cardiovasc Res; 2004 Dec 01; 64(3):526-35. PubMed ID: 15537506
    [Abstract] [Full Text] [Related]

  • 23. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
    Stumpf C, Petzi S, Seybold K, Wasmeier G, Arnold M, Raaz D, Yilmaz A, Daniel WG, Garlichs CD.
    Clin Sci (Lond); 2009 Jan 01; 116(1):45-52. PubMed ID: 18459941
    [Abstract] [Full Text] [Related]

  • 24. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
    Huang BS, White RA, Ahmad M, Tan J, Jeng AY, Leenen FH.
    Cardiovasc Res; 2009 Feb 15; 81(3):574-81. PubMed ID: 18689429
    [Abstract] [Full Text] [Related]

  • 25. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair.
    Hsu CP, Huang CY, Wang JS, Sun PC, Shih CC.
    Ann Thorac Surg; 2008 Oct 15; 86(4):1243-9. PubMed ID: 18805169
    [Abstract] [Full Text] [Related]

  • 26. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
    Kompa AR, See F, Lewis DA, Adrahtas A, Cantwell DM, Wang BH, Krum H.
    J Pharmacol Exp Ther; 2008 Jun 15; 325(3):741-50. PubMed ID: 18334667
    [Abstract] [Full Text] [Related]

  • 27. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
    Li GH, Shi Y, Chen Y, Sun M, Sader S, Maekawa Y, Arab S, Dawood F, Chen M, De Couto G, Liu Y, Fukuoka M, Yang S, Da Shi M, Kirshenbaum LA, McCulloch CA, Liu P.
    Circ Res; 2009 Apr 10; 104(7):896-904. PubMed ID: 19246681
    [Abstract] [Full Text] [Related]

  • 28. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M, Tatsumi T, Matsunaga S, Hayashi H, Kimata M, Honsho S, Nishikawa S, Mano A, Shiraishi J, Yamada H, Takahashi T, Matoba S, Kobara M, Matsubara H.
    Hypertens Res; 2007 May 10; 30(5):427-37. PubMed ID: 17587755
    [Abstract] [Full Text] [Related]

  • 29. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
    Timmers L, van Keulen JK, Hoefer IE, Meijs MF, van Middelaar B, den Ouden K, van Echteld CJ, Pasterkamp G, de Kleijn DP.
    Circ Res; 2009 Mar 13; 104(5):699-706. PubMed ID: 19168865
    [Abstract] [Full Text] [Related]

  • 30. Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction.
    Tsujita K, Kaikita K, Hayasaki T, Honda T, Kobayashi H, Sakashita N, Suzuki H, Kodama T, Ogawa H, Takeya M.
    Circulation; 2007 Apr 10; 115(14):1904-11. PubMed ID: 17389263
    [Abstract] [Full Text] [Related]

  • 31. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction.
    Sugano Y, Anzai T, Yoshikawa T, Maekawa Y, Kohno T, Mahara K, Naito K, Ogawa S.
    Cardiovasc Res; 2005 Feb 01; 65(2):446-56. PubMed ID: 15639484
    [Abstract] [Full Text] [Related]

  • 32. Cardiac remodeling by fibrous tissue after infarction in rats.
    Sun Y, Zhang JQ, Zhang J, Lamparter S.
    J Lab Clin Med; 2000 Apr 01; 135(4):316-23. PubMed ID: 10779047
    [Abstract] [Full Text] [Related]

  • 33. Biglycan is required for adaptive remodeling after myocardial infarction.
    Westermann D, Mersmann J, Melchior A, Freudenberger T, Petrik C, Schaefer L, Lüllmann-Rauch R, Lettau O, Jacoby C, Schrader J, Brand-Herrmann SM, Young MF, Schultheiss HP, Levkau B, Baba HA, Unger T, Zacharowski K, Tschöpe C, Fischer JW.
    Circulation; 2008 Mar 11; 117(10):1269-76. PubMed ID: 18299507
    [Abstract] [Full Text] [Related]

  • 34. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction.
    Sumida A, Horiba M, Ishiguro H, Takenaka H, Ueda N, Ooboshi H, Opthof T, Kadomatsu K, Kodama I.
    Cardiovasc Res; 2010 Apr 01; 86(1):113-21. PubMed ID: 19969622
    [Abstract] [Full Text] [Related]

  • 35. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction.
    Smith RS, Agata J, Xia CF, Chao L, Chao J.
    Life Sci; 2005 Apr 08; 76(21):2457-71. PubMed ID: 15763077
    [Abstract] [Full Text] [Related]

  • 36. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy.
    Jayasankar V, Pirolli TJ, Bish LT, Berry MF, Burdick J, Grand T, Woo YJ.
    J Mol Cell Cardiol; 2004 Apr 08; 36(4):531-8. PubMed ID: 15081312
    [Abstract] [Full Text] [Related]

  • 37. Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.
    Du XJ, Gao XM, Kiriazis H, Moore XL, Ming Z, Su Y, Finch AM, Hannan RA, Dart AM, Graham RM.
    Cardiovasc Res; 2006 Sep 01; 71(4):735-43. PubMed ID: 16859660
    [Abstract] [Full Text] [Related]

  • 38. Persistent cardiac aldosterone synthesis in angiotensin II type 1A receptor-knockout mice after myocardial infarction.
    Katada J, Meguro T, Saito H, Ohashi A, Anzai T, Ogawa S, Yoshikawa T.
    Circulation; 2005 May 03; 111(17):2157-64. PubMed ID: 15851599
    [Abstract] [Full Text] [Related]

  • 39. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling.
    Kohno T, Anzai T, Naito K, Miyasho T, Okamoto M, Yokota H, Yamada S, Maekawa Y, Takahashi T, Yoshikawa T, Ishizaka A, Ogawa S.
    Cardiovasc Res; 2009 Feb 15; 81(3):565-73. PubMed ID: 18984601
    [Abstract] [Full Text] [Related]

  • 40. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
    Adamek A, Hu K, Bayer B, Wagner H, Ertl G, Bauersachs J, Frantz S.
    Basic Res Cardiol; 2007 Jul 15; 102(4):334-40. PubMed ID: 17340057
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 38.